Dr_Camilla_Easter_CEO_of_Oxford_Medical_Products

Oxford Medical Products closes £1.2 million for weight loss technology

Oxford Medical Products (OMP) has raised £1.2M in seed investment to develop a safe and affordable weight loss capsule, which uses the same mechanism of action as a gastric balloon, but can be taken at home. The funding will be used to complete pre-clinical testing, upscale and outsource manufacturing and grow the team. The funding was led by Ada Ventures with Selvedge Venture alongside several angel investors including Dr Nick Edwards, a founder of the company, and Dr Jan Hruska, co-founder of Sophos.

image

OMP receives €1.3 million for Sirona self-expanding hydrogel weight loss capsule

Oxford Medical Products (OMP) has raised €1.3 million to develop a safe and affordable weight loss capsule, which uses the same mechanism of action as a gastric balloon, but can be taken at home. The funding will be used to complete pre-clinical testing, upscale and outsource manufacturing and develop the company’s workforce.

The company’s non-surgical weight loss technology Sirona, is a self-expanding hydrogel capsule that once swallowed expands in the stomach, reducing hunger and, the company claims, leading to significant weight loss. The capsules stay in the stomach for several weeks before breaking down gradually and passing naturally over time.

Oxford Medical Products was founded in 2017 by Professor Jan Czenurska a world-renowned expert in hydrogels, and Dr Hutan Ashrafian a pioneering bariatric surgeon – with Dr Camilla Easter and Dr Nick Edwards, two medically trained entrepreneurs, joining Oxford Medical Products soon after.